VERA

Vera Therapeutics, Inc.

• Seeking Alpha·20h ago

  Vera Therapeutics: Strong IgAN Data, But Differentiation Is Still Pending

• TipRanks·1d ago

  Vera Therapeutics Stockholders Back Board, Governance Proposals

• PUBT·1d ago

  Vera Therapeutics shareholders elect Class II directors at annual meeting

• TipRanks·4d ago

  Analysts’ Top Healthcare Picks: Concentra Group Holdings Parent, Inc. (CON), Vera Therapeutics (VERA)

• TipRanks·5d ago

  Analysts Are Bullish on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Vera Therapeutics (VERA)

• Dow Jones·05/15 17:49

  Vera Therapeutics Price Target Cut to $91.00/Share From $95.00 by Evercore ISI Group

• Dow Jones·05/15 17:49

  Vera Therapeutics Is Maintained at Outperform by Evercore ISI Group

• Benzinga·05/15 17:39

  Evercore ISI Group Maintains Outperform on Vera Therapeutics, Lowers Price Target to $91

• TipRanks·05/15 12:37

  Vera Therapeutics (VERA) Receives a Buy from Evercore ISI

• TipRanks·05/15 12:28

  Vera Therapeutics price target lowered to $91 from $95 at Evercore ISI

• PUBT·05/13 20:27

  Vera Therapeutics CEO Marshall Fordyce disposes 18,500 shares for $834,058

• TipRanks·05/12 10:27

  Analyst Reiterates Buy on Vera as Atacicept Progress and Strong Cash Position Support Unchanged $110 Price Target

• TipRanks·05/11 11:49

  Vera Therapeutics (VERA) Receives a Buy from Guggenheim

• PUBT·05/08 20:05

  Vera Therapeutics grants inducement equity awards to 10 new hires, sets options at $35.51

• Reuters·05/08 20:05

  VERA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)